Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells

被引:247
作者
Chauhan, D
Kharbanda, S
Ogata, A
Urashima, M
Teoh, G
Robertson, M
Kufe, DW
Anderson, KC
机构
[1] HARVARD UNIV, DIV HEMATOL MALIGNANCIES,DANA FARBER CANC INST, SCH MED,DEPT MED, BOSTON, MA 02115 USA
[2] HARVARD UNIV, DIV CANC PHARMACOL,DANA FARBER CANC INST,SCH MED, DEPT MED, BOSTON, MA 02115 USA
关键词
D O I
10.1182/blood.V89.1.227.227_227_234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fas belongs to the family of type-1 membrane proteins that transduce apoptotic signals. In the present studies, we characterized signaling during Fas-induced apoptosis in RPMI-8226 and IM-9 multiple myeloma (MM) derived cell lines as well as patient plasma cell leukemia cells. Treatment with anti-pas (7C11) monoclonal antibody (MoAb) induced apoptosis, evidenced by internucleosomal DNA fragmentation and propidium iodide staining, and was associated with increased expression of c-jun early response gene. We also show that anti-fas MoAb treatment is associated with activation of stress-activated protein kinase (SAPK) and p38 mitogen-activated protein kinase (MAPK); however, no detectable increase in extracellular signal-regulated kinases (ERK1 and ERK2) activity was observed. Because interleukin-6 (IL-6) is a growth factor for MM cells and inhibits apoptosis induced by dexamethasone and serum starvation, we examined whether IL-6 affects anti-fas MoAb-induced apoptosis and activation of SAPK or p38 MAPK in MM cells. Culture of MM cells with IL-6 before treatment with anti-fas MoAb significantly reduced both DNA fragmentation and activation of SAPK, without altering induction of p38 MAPK activity. These results therefore suggest that anti-fas MoAb-induced apoptosis in MM cells is associated with activation of SAPK, and that IL-6 may both inhibit apoptosis and modulate SAPK activity. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:227 / 234
页数:8
相关论文
共 67 条
[1]  
ANDERSON KC, 1989, BLOOD, V73, P1915
[2]   THE JUN PROTO-ONCOGENE IS POSITIVELY AUTOREGULATED BY ITS PRODUCT, JUN/AP-1 [J].
ANGEL, P ;
HATTORI, K ;
SMEAL, T ;
KARIN, M .
CELL, 1988, 55 (05) :875-885
[3]   ONCOGENE JUN ENCODES A SEQUENCE-SPECIFIC TRANS-ACTIVATOR SIMILAR TO AP-1 [J].
ANGEL, P ;
ALLEGRETTO, EA ;
OKINO, ST ;
HATTORI, K ;
BOYLE, WJ ;
HUNTER, T ;
KARIN, M .
NATURE, 1988, 332 (6160) :166-171
[4]   ROLE OF INTERLEUKIN-6 IN THE GROWTH OF MYELOMA-DERIVED CELL-LINES [J].
BARUT, BA ;
ZON, LI ;
COCHRAN, MK ;
PAUL, SR ;
CHAUHAN, D ;
MOHRBACHER, A ;
FINGEROTH, J ;
ANDERSON, KC .
LEUKEMIA RESEARCH, 1992, 16 (10) :951-959
[5]   SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS [J].
BATAILLE, R ;
JOURDAN, M ;
ZHANG, XG ;
KLEIN, B .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2008-2011
[6]  
BILLADEAU D, 1995, CANCER RES, V55, P3640
[7]   INDUCTION OF THE TRPM-2 GENE IN CELLS UNDERGOING PROGRAMMED DEATH [J].
BUTTYAN, R ;
OLSSON, CA ;
PINTAR, J ;
CHANG, CS ;
BANDYK, M ;
NG, PY ;
SAWCZUK, IS .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (08) :3473-3481
[8]  
CALIGARISCAPPIO F, 1991, BLOOD, V77, P2688
[9]   ONCOSTATIN-M INDUCES ASSOCIATION OF GRB2 WITH JANUS KINASE JAK2 IN MULTIPLE-MYELOMA CELLS [J].
CHAUHAN, D ;
KHARBANDA, SM ;
OGATA, A ;
URASHIMA, M ;
FRANK, D ;
MALIK, N ;
KUFE, DW ;
ANDERSON, KC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1801-1806
[10]  
CHAUHAN D, 1994, BLOOD, V84, P2243